Apowiser, a Ra’Anana, Israel-based provider of a chatbot-based system to support customers in the online purchase of Over-the-Counter (OTC) drugs, raised $1.5m in seed funding.
The round was led by Longliv Ventures, a member of CK Hutchinson Holdings Limited.
Co-founded in 2021 by Prof. Eyal Schwartzberg, the former Head of Pharmaceutical & Enforcement Divisions of the Israeli Ministry of Health, Apowiser has developed PharmAssist, a novel digital online platform that assists consumers when they look to treat themselves with OTC medications. It allows consumers in a quick and discreet manner, to learn more about their condition, identify issues that should be escalated to a healthcare provider, check for allergies and potential sensitivities to ingredients of OTC medications, and purchase an appropriate OTC product. PharmAssist is based on published medication data and a deep understanding of the practices of pharmacists. The current platform covers more than 600 OTC drugs & complimentary products, enabling treatment for more than 40 healthcare scenarios.
PharmAssist is already in use by Super-Pharm, Israel’s largest drugstore chain, operating more than 280 branches across the country with an accompanying strong online presence.
FinSMEs
22/06/2022